Companies in public sources

Eli Lilly and Company

Company documents and their place in the pharmaceutical supply chain.

Companies, institutions and data are cited as public industry context. These references do not imply partnership, endorsement, certification or a commercial relationship with our company.

Published company information

Use the linked sources to review the activities, dates and relationships explicitly described by this company.

Independent reference

This entry provides industry context. Mentioning a company or displaying its identity does not imply endorsement, affiliation or a commercial relationship with BLOPEP.

Sources and verification scope

Corporate disclosure · S07

Eli Lilly and Company Form 10-K, fiscal year 2025 ↗

SEC · filing by Eli Lilly and Company

Source details (original language)
Scope
Lilly reports reliance on China-based suppliers for portions of its supply chain
Document section
Manufacturing and supply, p. 21; third-party supply chain risk factors
Limitations
Does not identify Bolang, peptide purchases from Bolang, partnership, endorsement or certification.
Claim verification date
2026-09-09

Related reading